BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11285663)

  • 1. Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children.
    Frick KD; Lietman TM; Holm SO; Jha HC; Chaudhary JS; Bhatta RC
    Bull World Health Organ; 2001; 79(3):201-7. PubMed ID: 11285663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Household willingness to pay for azithromycin treatment for trachoma control in the United Republic of Tanzania.
    Frick KD; Lynch M; West S; Munoz B; Mkocha HA
    Bull World Health Organ; 2003; 81(2):101-7. PubMed ID: 12751418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal.
    Holm SO; Jha HC; Bhatta RC; Chaudhary JS; Thapa BB; Davis D; Pokhrel RP; Yinghui M; Zegans M; Schachter J; Frick KD; Tapert L; Lietman TM
    Bull World Health Organ; 2001; 79(3):194-200. PubMed ID: 11285662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of trachoma control in seven world regions.
    Baltussen RM; Sylla M; Frick KD; Mariotti SP
    Ophthalmic Epidemiol; 2005 Apr; 12(2):91-101. PubMed ID: 16019692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali.
    Schémann JF; Guinot C; Traore L; Zefack G; Dembele M; Diallo I; Traore A; Vinard P; Malvy D
    Acta Trop; 2007 Jan; 101(1):40-53. PubMed ID: 17239332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
    Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF
    Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.
    Fraser-Hurt N; Bailey RL; Cousens S; Mabey D; Faal H; Mabey DC
    Bull World Health Organ; 2001; 79(7):632-40. PubMed ID: 11477966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.
    Bowman RJ; Sillah A; Van Dehn C; Goode VM; Muqit MM; Johnson GJ; Milligan P; Rowley J; Faal H; Bailey RL
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4074-9. PubMed ID: 11095598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana.
    Solomon AW; Akudibillah J; Abugri P; Hagan M; Foster A; Bailey RL; Mabey DC
    Bull World Health Organ; 2001; 79(1):8-14. PubMed ID: 11217675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania.
    Broman AT; Shum K; Munoz B; Duncan DD; West SK
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):99-104. PubMed ID: 16384950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplification and improvement of height-based azithromycin treatment for paediatric trachoma.
    Basilion EV; Kilima PM; Mecaskey JW
    Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):6-12. PubMed ID: 15550255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of azithromycin treatment of active trachoma in Omani school children.
    Khandekarf R; Mohammed AJ
    East Mediterr Health J; 2003; 9(5-6):1026-33. PubMed ID: 16450533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas?
    Bird M; Dawson CR; Schachter JS; Miao Y; Shama A; Osman A; Bassem A; Lietman TM
    J Infect Dis; 2003 May; 187(10):1669-73. PubMed ID: 12721948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Youth health care: much prevention for little money].
    Verloove-Vanhorick SP; Verkerk PH; van Leerdam FJ; Reijneveld SA; Hirasing RA
    Ned Tijdschr Geneeskd; 2003 May; 147(19):895-8. PubMed ID: 12768801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania.
    Wolle MA; Muñoz BE; Mkocha H; West SK
    Ophthalmology; 2009 Feb; 116(2):243-7. PubMed ID: 19091415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of clinical effectiveness and direct costs of azithromycin treatment for exacerbation of chronic obstructive pulmonary disease in hospitalized patients and ambulatory care].
    Faber M; Jahnz-Rózyk K; Kucharczyk A; Targowski T; From S; Mamełka B
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():96-9. PubMed ID: 15524029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the Integrated Management of Childhood Illness cost more than routine care? Results from the United Republic of Tanzania.
    Adam T; Manzi F; Schellenberg JA; Mgalula L; de Savigny D; Evans DB
    Bull World Health Organ; 2005 May; 83(5):369-77. PubMed ID: 15976878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.